SAN MATEO, Calif.–(BUSINESS WIRE)–The numbers speak for themselves, RapidAI’s deep clinical AI is delivering results where competitors are falling short. New data from the largest head-to-head study to date proves RapidAI’s LVO detection outperforms Viz.ai by a staggering 33%, detecting far more stroke cases and reducing the risk of missed diagnoses. These findings, along with 17 influential studies, will be showcased at the American Heart Association’s International Stroke Conference (ISC) i
More in Trade Show
Trade Show
Japońskie Stowarzyszenie Producentów Sake i Shōchū ogłasza dane dotyczące eksportu sake w 2024 roku: rekordowy eksport do 80 krajów i wzrost o 6% rok do roku
TOKIO–(BUSINESS WIRE)–Wyniki eksportu sake w 2024 roku Japońskie Stowarzyszenie Producentów Sake i Shōchū ...
Trade Show
ComEd Announces $100 Million in EV Rebates Now Available to Boost Charging and EV Adoption Across Northern Illinois
CHICAGO–(BUSINESS WIRE)–ComEd today joined a variety of local and industry stakeholders at the ...
Trade Show
NY NOW 2025 Winter Market Successfully Ignites Innovation, Connection & The Future of Retail
NEW YORK–(BUSINESS WIRE)–The NY NOW 2025 Winter Market, held from February 2 – ...